Advances in the systemic management of follicular lymphoma

July 20, 2018

Source: Oncology Times
Author: Dr. Alan Tan
Published: July 20, 2018

Follicular lymphoma is the second more common subtype of non-Hodgkin lymphoma and the most common indolent non-Hodgkin lymphoma. Despite the fact that follicular lymphoma is not typically curable with conventional treatment, current treatments are extending medial survival by more than 14 years. Dr. Alan Tan, Clinical Research Medical Director, Medical Oncologist and Hematologist at Cancer Treatment Centers of America® in Phoenix, discusses advancements in the systemic management of follicular lymphoma.

Read full article